Literature DB >> 9817973

Altered proliferative and metastatic potential associated with increased expression of syndecan-1.

K Hirabayashi1, F Numa, Y Suminami, A Murakami, T Murakami, H Kato.   

Abstract

The process of metastasis involves a series of sequential steps in which malignant cells are released from the primary tumor and metastasize to distant sites. Syndecan-1 is a cell surface proteoglycan that mediates cell adhesion and undergoes changes upon cell transformation of some cells that may contribute to the process of metastasis. To investigate the possible role of syndecan-1 in cell proliferation and metastatic potential, we employed a highly metastatic cell line (KLN 205) derived from mouse lung squamous cell carcinoma that expressed moderate amounts of syndecan-1. At first, endogenous syndecan-1 production was inhibited by an antisense oligodeoxynucleotides (ODNs). Since antisense ODNs of syndecan-1 inhibited cell growth, we established stable transfectants of syndecan-1 in this cell line to examine a proliferative advantage with the level of syndecan-1 expression. Overexpresser cells grew at a significantly faster rate than the vector-transfected control and showed greater incidence of tumor formation when injected subcutaneously into nude mice. Surprisingly, overexpresser cells enhanced pulmonary metastasis when injected intravenously. These results indicate that syndecan-1 expression plays a role in the control of cell proliferation and suggest that syndecan-1 expression may be involved in facilitating distant metastasis of tumor cells once they managed to enter the bloodstream (after intravasation steps).

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9817973     DOI: 10.1159/000030037

Source DB:  PubMed          Journal:  Tumour Biol        ISSN: 1010-4283


  5 in total

1.  Effect of syndecan-1 overexpression on mesenchymal tumour cell proliferation with focus on different functional domains.

Authors:  F Zong; E Fthenou; J Castro; B Péterfia; I Kovalszky; L Szilák; G Tzanakakis; K Dobra
Journal:  Cell Prolif       Date:  2009-10-13       Impact factor: 6.831

2.  E-Cadherin and Syndecan-1 Expression in Patients With Advanced Non-small Cell Lung Cancer Treated With Chemoradiotherapy.

Authors:  Pinelopi Gkogkou; Evangelia Peponi; Dimitrios Ntaskagiannis; Samuel Murray; Asimo Demou; Ioannis Sainis; Elli Ioakeim; Evangelos Briasoulis; Pericles Tsekeris
Journal:  In Vivo       Date:  2020 Jan-Feb       Impact factor: 2.155

Review 3.  Syndecans in tumor cell adhesion and signaling.

Authors:  DeannaLee M Beauvais; Alan C Rapraeger
Journal:  Reprod Biol Endocrinol       Date:  2004-01-07       Impact factor: 5.211

4.  Effect of the Expression of ELOVL5 and IGFBP6 Genes on the Metastatic Potential of Breast Cancer Cells.

Authors:  Sergey Nikulin; Galina Zakharova; Andrey Poloznikov; Maria Raigorodskaya; Daniel Wicklein; Udo Schumacher; Stepan Nersisyan; Jonas Bergquist; Georgy Bakalkin; Lidiia Astakhova; Alexander Tonevitsky
Journal:  Front Genet       Date:  2021-06-02       Impact factor: 4.599

5.  Molecular targets and signaling pathways regulated by nuclear translocation of syndecan-1.

Authors:  Tünde Szatmári; Filip Mundt; Ashish Kumar-Singh; Lena Möbus; Rita Ötvös; Anders Hjerpe; Katalin Dobra
Journal:  BMC Cell Biol       Date:  2017-12-08       Impact factor: 4.241

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.